Whether one is right for you depends on your goals, lifestyle, and the results youre after
Although the findings in the CANVAS trial showed a higher risk of amputation when taking canafliglozin compared to placebo [92], no significant difference in the risk of this complication was observed in the CREDENCE study [88]
The large image can be enlarged further using the zoom button by the main image
These discrepancies may arise from variations in sample sizes and the methods used to measure GLP-1 hormones, as well as poor medication reporting during data collection
Villumsen M, Schelde AB, Jimenez-Solem E, Jess T, Allin KH
Although some new research suggests GLP-1 agonists might improve UC, its important to monitor your symptoms carefully when taking any new medications